Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Agrees to Priority Review for First ADPKD Therapy
FDA Agrees to Priority Review for First ADPKD Therapy
FDA Agrees to Priority Review for First ADPKD Therapy
Submitted by
admin
on April 13, 2013 - 12:15pm
Source:
Monthly Prescribing Reference
News Tags:
Tolvaptan
autosomal dominant polycystic kidney disease
Headline:
FDA Agrees to Priority Review for First ADPKD Therapy
Do Not Allow Advertisers to Use My Personal information
